These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7871336)

  • 1. Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.
    Pirner K; Rascu A; Nürnberg W; Rubbert A; Kalden JR; Manger B
    Rheumatol Int; 1994; 14(4):169-74. PubMed ID: 7871336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations.
    Termaat RM; Brinkman K; Nossent JC; Swaak AJ; Smeenk RJ; Berden JH
    Clin Exp Immunol; 1990 Nov; 82(2):268-74. PubMed ID: 2242607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
    Shibata S; Sasaki T; Harpel P; Fillit H
    Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new ELISA for the detection of anti-heparan sulfate reactivity, using photobiotinylated antigen.
    Hylkema MN; Kramers C; Van der Wal TJ; Van Bruggen MC; Swaak AJ; Berden JH; Smeenk RJ
    J Immunol Methods; 1994 Nov; 176(1):33-43. PubMed ID: 7963593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis?
    Berden JH; Termaat RM; Brinkman K; Smeenk RJ; Swaak AJ; Faaber P; Assmann K; van de Heuvel LP; Veerkamp JH
    Nephrologie; 1989; 10(3):127-32. PubMed ID: 2532712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis.
    Kramers C; Termaat RM; ter Borg EJ; van Bruggen MC; Kallenberg CG; Berden JH
    Clin Exp Immunol; 1993 Jul; 93(1):34-8. PubMed ID: 8324902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigens.
    Williams RC; Malone CC; Cimbalnik K; Presley MA; Roux KH; Strelets L; Silvestris F
    Arthritis Rheum; 1997 Jan; 40(1):109-23. PubMed ID: 9008607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
    Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
    J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis.
    Hylkema MN; Zwet IV; Kramers C; Van Bruggen MC; Swaak AJ; Berden JH; Smeenk RJ
    Clin Exp Immunol; 1995 Jul; 101(1):55-9. PubMed ID: 7621592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes.
    Termaat RM; Brinkman K; van Gompel F; van den Heuvel LP; Veerkamp JH; Smeenk RJ; Berden JH
    J Autoimmun; 1990 Oct; 3(5):531-45. PubMed ID: 2252523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA.
    Srdic-Rajic T; Jurisic V; Andrejevic S; Bonaci-Nikolic B; Bowker T; Concas D; Metlas R
    Immunobiology; 2012 Jan; 217(1):111-7. PubMed ID: 21840618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes.
    Faaber P; Rijke TP; van de Putte LB; Capel PJ; Berden JH
    J Clin Invest; 1986 Jun; 77(6):1824-30. PubMed ID: 2940265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulphate-ELISA gives false positive results for anti-DNA-DNA/histone immune complexes in sera of patients with SLE.
    Suenaga R; Abdou NI
    Lupus; 1995 Feb; 4(1):57-62. PubMed ID: 7539323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.
    Ravirajan CT; Rowse L; MacGowan JR; Isenberg DA
    Rheumatology (Oxford); 2001 Dec; 40(12):1405-12. PubMed ID: 11752513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients.
    Hylkema MN; van Bruggen MC; ten Hove T; de Jong J; Swaak AJ; Berden JH; Smeenk RJ
    J Autoimmun; 2000 Mar; 14(2):159-68. PubMed ID: 10677247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reactivity of sera from patients with systemic lupus erythematosus to seven different species of single and double stranded deoxyribonucleic acids.
    Yu CL; Huang MH; Tsai CY; Sun KH; Hsieh SC; Tsai YY; Tsai ST; Yu HS; Han SH
    Clin Exp Rheumatol; 1996; 14(2):137-44. PubMed ID: 8737719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate.
    Ofosu-Appiah W; Sfeir G; Viti D; Burashnikova E
    Cell Immunol; 1998 Jan; 183(1):22-31. PubMed ID: 9578716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus.
    Sun Y; Fong KY; Chung MC; Yao ZJ
    Int Immunol; 2001 Feb; 13(2):223-32. PubMed ID: 11157855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
    Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.